Cytogen Quick Ratio

What does Cytogen do? Cytogen Inc, listed on the Korean stock market with ticker 217330.KQ and ISIN KR727330000, is a biotechnology company based in Seoul, South Korea. The company, which went public on November 22, 2018, employs 43 full-time staff. Cytogen Inc focuses on the research and development of cancer treatment solutions, particularly in the field of liquid biopsy applications. Its services include biomarker discovery and verification, such as circulating tumor cell (CTC)-based biomarker analysis, gene mutation and transcript expression studies, and drug testing. The company also provides liquid biopsy-based precision medical services, including companion diagnostics development, therapeutic drug re-selection, treatment effectiveness monitoring, and recurrence prediction. Cytogen Inc develops and sells platforms and kits for liquid biopsy, distributing its products domestically in South Korea and internationally. The company's website is http://www.cytogenlab.com. As a biotechnology firm operating within the healthcare sector, Cytogen Inc is engaged in advancing cancer diagnostics and treatment through innovative liquid biopsy technologies. Cytogen is one of the most popular companies on Eulerpool.